Schedule of Credit Risk for Contingent Loans |
As of December
31, 2024 and 2023, for credit risk for contingent loans is composed as follows:
| |
Outstanding
exposure | | |
ECL | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
MCh$ | | |
MCh$ | | |
MCh$ | | |
MCh$ | |
Warranty by endorsement and sureties | |
| 336,737 | | |
| 351,531 | | |
| 1,505 | | |
| 1,576 | |
Confirmed foreign letters of credit | |
| 160,856 | | |
| 83,392 | | |
| 92 | | |
| 43 | |
Issued foreign letters of credit | |
| 281,360 | | |
| 267,212 | | |
| 321 | | |
| 285 | |
Performance guarantees | |
| 3,124,626 | | |
| 2,640,297 | | |
| 16,923 | | |
| 20,565 | |
Undrawn credit lines | |
| 11,125,300 | | |
| 10,084,458 | | |
| 68,555 | | |
| 66,747 | |
Other commitments | |
| 51,889 | | |
| 120,545 | | |
| 89 | | |
| 424 | |
Total | |
| 15,080,768 | | |
| 13,547,435 | | |
| 87,485 | | |
| 89,640 | |
|
Schedule of Credit Quality and the Maximum Exposure to Credit Risk Based on the Bank’s |
The table below shows the credit quality
and the maximum exposure to credit risk based on the Bank’s internal credit rating system and year-end stage classification as of
December 31, 2024 and 2023.
| |
As of December 31, 2024 | | |
| | |
As of December 31, 2023 | | |
| |
| |
Stage 1 | | |
Stage 2 | | |
Stage 3 | | |
| | |
Stage 1 | | |
Stage 2 | | |
Stage 3 | | |
| |
| |
Individual
MCh$ | | |
Group
MCh$ | | |
Individual
MCh$ | | |
Group
MCh$ | | |
Individual
MCh$ | | |
Group
MCh$ | | |
Total MCh$ | | |
Individual
MCh$ | | |
Group
MCh$ | | |
Individual
MCh$ | | |
Group
MCh$ | | |
Individual
MCh$ | | |
Group
MCh$ | | |
Total MCh$ | |
Normal | |
| 5,328,378 | | |
| 9,397,036 | | |
| 19,936 | | |
| 262,865 | | |
| — | | |
| — | | |
| 15,008,215 | | |
| 4,775,026 | | |
| 8,422,110 | | |
| 16,665 | | |
| 254,564 | | |
| — | | |
| — | | |
| 13,468,365 | |
Substandard | |
| — | | |
| — | | |
| 40,227 | | |
| — | | |
| — | | |
| — | | |
| 40,227 | | |
| — | | |
| — | | |
| 51,625 | | |
| — | | |
| — | | |
| — | | |
| 51,625 | |
Non-complying | |
| — | | |
| — | | |
| — | | |
| — | | |
| 24,503 | | |
| 7,823 | | |
| 32,326 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 18,861 | | |
| 8,584 | | |
| 27,445 | |
Total | |
| 5,328,378 | | |
| 9,397,036 | | |
| 60,163 | | |
| 262,865 | | |
| 24,503 | | |
| 7,823 | | |
| 15,080,768 | | |
| 4,775,026 | | |
| 8,422,110 | | |
| 68,290 | | |
| 254,564 | | |
| 18,861 | | |
| 8,584 | | |
| 13,547,435 | |
|
Schedule of Changes in Outstanding Exposures and Corresponding Allowance |
An analysis of changes in the outstanding
exposures and corresponding provision for ECL during the 2024 and 2023 periods are as follows:
| |
Stage
1 | | |
Stage
2 | | |
Stage
3 | | |
| | |
| |
| |
Individual | | |
Group | | |
Individual | | |
Group | | |
Individual | | |
Group | | |
Total | |
| |
Gross
carrying
amount MCh$ | | |
ECL MCh$ | | |
Gross
carrying
amount MCh$ | | |
ECL MCh$ | | |
Gross
carrying
amount MCh$ | | |
ECL MCh$ | | |
Gross
carrying
amount MCh$ | | |
ECL MCh$ | | |
Gross
carrying
amount MCh$ | | |
ECL MCh$ | | |
Gross
carrying
amount MCh$ | | |
ECL MCh$ | | |
Gross
carrying
amount MCh$ | | |
ECL MCh$ | |
Outstanding exposure as of January 1, 2024 | |
| 4,775,026 | | |
| 12,464 | | |
| 8,422,110 | | |
| 59,093 | | |
| 68,290 | | |
| 6,242 | | |
| 254,564 | | |
| 2,364 | | |
| 18,861 | | |
| 5,417 | | |
| 8,584 | | |
| 4,060 | | |
| 13,547,435 | | |
| 89,640 | |
Net
change on exposures | |
| 446,635 | | |
| (2,010 | ) | |
| 640,430 | | |
| 1,862 | | |
| (10,584 | ) | |
| (1,642 | ) | |
| (61,617 | ) | |
| (72 | ) | |
| (5,580 | ) | |
| (2,106 | ) | |
| (6,498 | ) | |
| (1,056 | ) | |
| 1,002,786 | | |
| (5,024 | ) |
Transfer
to Stage 1 | |
| 51,618 | | |
| 278 | | |
| 724,421 | | |
| 9,166 | | |
| (51,590 | ) | |
| (269 | ) | |
| (718,951 | ) | |
| (6,839 | ) | |
| (28 | ) | |
| (9 | ) | |
| (5,470 | ) | |
| (2,327 | ) | |
| — | | |
| — | |
Transfer
to Stage 2 | |
| (64,150 | ) | |
| (178 | ) | |
| (781,359 | ) | |
| (6,138 | ) | |
| 64,276 | | |
| 242 | | |
| 781,686 | | |
| 6,272 | | |
| (126 | ) | |
| (64 | ) | |
| (327 | ) | |
| (134 | ) | |
| — | | |
| — | |
Transfer
to Stage 3 | |
| (230 | ) | |
| (1 | ) | |
| (4,778 | ) | |
| (55 | ) | |
| (11,105 | ) | |
| (172 | ) | |
| (6,390 | ) | |
| (1,511 | ) | |
| 11,335 | | |
| 173 | | |
| 11,168 | | |
| 1,566 | | |
| — | | |
| — | |
Impact
on year-end ECL of exposures transferred between stages during the year | |
| — | | |
| (137 | ) | |
| — | | |
| (4,400 | ) | |
| — | | |
| 497 | | |
| — | | |
| 2,192 | | |
| — | | |
| 1,314 | | |
| — | | |
| 1,359 | | |
| — | | |
| 825 | |
Refinements
to models used for calculation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
Foreign
exchange adjustments | |
| 119,479 | | |
| 268 | | |
| 396,212 | | |
| 1,500 | | |
| 876 | | |
| 25 | | |
| 13,573 | | |
| 54 | | |
| 41 | | |
| 23 | | |
| 366 | | |
| 174 | | |
| 530,547 | | |
| 2,044 | |
Total | |
| 5,328,378 | | |
| 10,684 | | |
| 9,397,036 | | |
| 61,028 | | |
| 60,163 | | |
| 4,923 | | |
| 262,865 | | |
| 2,460 | | |
| 24,503 | | |
| 4,748 | | |
| 7,823 | | |
| 3,642 | | |
| 15,080,768 | | |
| 87,485 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Outstanding
exposure as of January 1, 2023 | |
| 4,622,212 | | |
| 13,964 | | |
| 7,908,219 | | |
| 101,406 | | |
| 106,552 | | |
| 16,785 | | |
| 223,861 | | |
| 1,724 | | |
| 17,709 | | |
| 3,654 | | |
| 12,242 | | |
| 5,956 | | |
| 12,890,795 | | |
| 143,489 | |
Net
change on exposures | |
| 134,675 | | |
| (3,390 | ) | |
| 532,694 | | |
| (36,053 | ) | |
| (37,786 | ) | |
| (4,364 | ) | |
| (67,851 | ) | |
| (1,166 | ) | |
| (6,624 | ) | |
| (3,062 | ) | |
| (6,297 | ) | |
| (1,003 | ) | |
| 548,811 | | |
| (49,038 | ) |
Transfer
to Stage 1 | |
| 125,611 | | |
| 6,860 | | |
| 724,027 | | |
| 8,188 | | |
| (125,550 | ) | |
| (6,811 | ) | |
| (719,174 | ) | |
| (5,503 | ) | |
| (61 | ) | |
| (49 | ) | |
| (4,853 | ) | |
| (2,685 | ) | |
| — | | |
| — | |
Transfer
to Stage 2 | |
| (134,046 | ) | |
| (381 | ) | |
| (819,344 | ) | |
| (8,505 | ) | |
| 134,146 | | |
| 450 | | |
| 819,755 | | |
| 8,712 | | |
| (100 | ) | |
| (69 | ) | |
| (411 | ) | |
| (207 | ) | |
| — | | |
| — | |
Transfer
to Stage 3 | |
| (505 | ) | |
| (1 | ) | |
| (3,613 | ) | |
| (46 | ) | |
| (7,409 | ) | |
| (1,161 | ) | |
| (4,232 | ) | |
| (385 | ) | |
| 7,914 | | |
| 1,162 | | |
| 7,845 | | |
| 431 | | |
| — | | |
| — | |
Impact
on year-end ECL of exposures transferred between stages during the year | |
| — | | |
| (6,476 | ) | |
| — | | |
| (2,110 | ) | |
| — | | |
| 1,382 | | |
| — | | |
| (2,001 | ) | |
| — | | |
| 3,769 | | |
| — | | |
| 1,482 | | |
| — | | |
| (3,954 | ) |
Refinements
to models used for calculation | |
| — | | |
| 1,862 | | |
| — | | |
| (4,016 | ) | |
| — | | |
| 231 | | |
| — | | |
| 979 | | |
| — | | |
| — | | |
| — | | |
| 61 | | |
| — | | |
| (883 | ) |
Foreign
exchange adjustments | |
| 27,079 | | |
| 26 | | |
| 80,127 | | |
| 229 | | |
| (1,663 | ) | |
| (270 | ) | |
| 2,205 | | |
| 4 | | |
| 23 | | |
| 12 | | |
| 58 | | |
| 25 | | |
| 107,829 | | |
| 26 | |
Total | |
| 4,775,026 | | |
| 12,464 | | |
| 8,422,110 | | |
| 59,093 | | |
| 68,290 | | |
| 6,242 | | |
| 254,564 | | |
| 2,364 | | |
| 18,861 | | |
| 5,417 | | |
| 8,584 | | |
| 4,060 | | |
| 13,547,435 | | |
| 89,640 | |
|